The efficacy and safety of azvudine (FNC) in phase 1 investigator-initiated study in patients with advanced solid tumors.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Xuemei Zhu, Hao Li, Shufang Zhang, Yanhua Zhou
Institutions: Shanghai Jiao Tong University, Ruijin Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162568517